Skip to main content
. 2006 Aug 11;44(2):107–121. doi: 10.1136/jmg.2006.044388

Table 3 Comparison of age at diagnosis in 191 families with at least one affected individual tested.

Status Families Cases
n* Mean (SD) n Mean† (SD)
(A) Breast cancer
BRCA1+ family 26 45.1 (7.5) 148 44.8 (11.7)
BRCA2+ family 29 49.3 (5.9) 191 48.6 (12.7)
No mutation detected 135 53.1 (6.9) 598 53.5 (12.4)
Overall: F2,187 = 26.3, p<0.0001; BRCA1/2v no mutation detected: F1,187 = 49.6, p<0.0001; BRCA1vBRCA2: F1,187 = 6.08, p = 0.015.
(B) Ovarian cancer
BRCA1+ family 22 52.8 (8.7) 42 52.1 (11.6)
BRCA2+ family 11 56.1 (6.4) 19 56.2 (10.2)
No mutation detected 29 58.5 (12.1) 35 58.4 (13.6)
Overall: F2,59 = 3.17, p = 0.04; BRCA1/2v no mutation detected: F1,59 = 3.13, p = 0.08; BRCA1vBRCA2: F1,59 = 1.74, p = 0.19.

BRCA1+, BRCA1 positive; BRCA2+, BRCA2 positive.

*Families with at least one case of breast or ovarian cancer, respectively.

†Analysis of variance of mean age at diagnosis per family, adjusted for number of cases.